ARTICLE | Clinical News
BetaKine: National Cancer Institute filed an IND
October 31, 1994 8:00 AM UTC
Celtrix Pharmaceuticals Inc. (CTRX) Product: BetaKine (TGF-beta-2) Indication: Oral mucositis, a side effect of cytotoxic cancer chemotherapy Status: National Cancer Institute filed an IND ...